The Ozempic Patient Assistance Program gets confused constantly with the Ozempic Savings Card, and the two are nothing alike. The Savings Card reduces a copay for people who already have insurance. The PAP provides the medication completely free to people who don't — but only within a narrower income band than most people expect, and with a 2026 rule change that removed an entire category of patients who used to qualify. This guide walks through exactly who's eligible, how much income is actually allowed, what paperwork you need, and what to do if Novo Nordisk turns you down.
1. What the Ozempic PAP Actually Provides
The Patient Assistance Program is a charitable access program run directly by Novo Nordisk. If you're approved, you receive Ozempic at no cost — not a coupon, not a reduced price, but free medication, typically shipped directly or coordinated through your prescriber's office. It's designed for people who have no other realistic path to affording the drug, which is why the eligibility bar is narrower than the manufacturer's other savings programs.
2. Full Eligibility Requirements
| Requirement | Detail |
|---|---|
| Insurance status | Uninsured, or in limited cases, Medicare without prescription drug coverage |
| Private/commercial insurance | Disqualifying — use the Savings Card instead |
| Medicare with Part D drug coverage | Disqualifying as of 2026 |
| Household income | At or below 200% of the federal poverty level |
| Medicaid enrollment | Disqualifying — must provide denial letter if eligible but income meets state thresholds |
| VA benefits | Disqualifying |
| Medicare Extra Help (LIS), income below 150% FPL | Must provide proof of denial to qualify |
| Prescriber signature | Required on the clinical portion of the application |
If you're eligible for Medicaid but haven't enrolled, you can't simply skip it — you must sign a patient declaration on the application confirming you don't intend to enroll in Medicaid, rather than just leaving that box unaddressed.
3. Income Limits by Household Size (2026)
Novo Nordisk sets the Ozempic-specific threshold at 200% of the federal poverty level, which scales up with household size. These are approximate 2026 figures for the 48 contiguous states; Alaska and Hawaii use higher thresholds.
| Household size | Approximate annual income limit |
|---|---|
| 1 person | ~$31,300 |
| 2 people | ~$42,300 |
| 3 people | ~$53,300 |
| 4 people | ~$64,300 |
| 5 people | ~$75,300 |
| 6 people | ~$86,300 |
Confirm the exact figures before applying. Federal poverty guidelines update annually and Novo Nordisk's application points to the NeedyMeds website for the current table. Use these numbers as a planning estimate, not a guarantee — verify against the current-year FPL chart when you actually submit your application.
4. The 2026 Eligibility Changes
Two changes took effect for 2026 that are worth understanding before you apply, especially if you or someone you're helping qualified in a prior year.
| Change | What it means |
|---|---|
| Medicare Part D beneficiaries excluded | Patients with Medicare prescription drug coverage can no longer receive Ozempic through the PAP, regardless of income |
| RYBELSUS® tablets removed from the PAP | Oral semaglutide is no longer covered under this assistance program for any patient category |
Novo Nordisk's stated reasoning for the Medicare change is that roughly 98% of Part D beneficiaries already have some form of Ozempic coverage through their plan, making free assistance largely redundant for that group. If you were previously approved as a Medicare patient, expect your next renewal to be affected by this change.
5. Documents You'll Need
| Document | When it's needed |
|---|---|
| Proof of household income (pay stubs, tax return, or unemployment statement) | Always required |
| Completed prescriber section with signature | Always required |
| Medicaid denial letter | If your income meets your state's Medicaid threshold |
| Signed patient declaration (won't enroll in Medicaid) | If Medicaid-eligible but not enrolled |
| Medicare Part D Extra Help denial letter | If applying as a Medicare patient with income below 150% FPL |
| Proof of U.S. citizenship or legal residency | Always required |
6. Step-by-Step: How to Apply
Download the application
Get the current PAP application in English or Spanish from novocare.com, or call Novo Nordisk at 1-866-310-7549 to have it mailed or faxed to you.
Gather your income documentation
Collect recent pay stubs for everyone in your household who works, or a recent tax return or unemployment statement if that applies better to your situation.
Have your prescriber complete their section
Your doctor or their office needs to fill out and sign the clinical portion confirming your diagnosis and prescription. Many offices can submit this directly through the NovoCare provider portal.
Attach any required denial letters
If you're potentially eligible for Medicaid or Medicare Extra Help, include the denial letter or signed declaration as applicable to your situation.
Submit and wait for a decision
Submit the completed application through the NovoCare portal, by mail, or by fax as directed, and expect a decision within a few weeks.
7. Processing Time and Annual Renewal
Most complete applications are processed within 2 to 4 weeks. While you wait, it's worth pricing the NovoCare Pharmacy self-pay option or a discount card as a bridge, since approval isn't guaranteed and delays happen when documentation is incomplete. If you're approved, expect to re-enroll annually — Novo Nordisk re-verifies your income and insurance status each year, so keep your documentation on hand for renewal rather than starting from scratch every time.
8. Common Denial Reasons and How to Fix Them
| Reason | How to address it |
|---|---|
| Income above the 200% FPL threshold | Re-check your household size calculation; a missed dependent can change your limit significantly |
| Has private or commercial insurance | Not eligible for PAP — apply for the Savings Card instead if your plan covers Ozempic |
| Enrolled in Medicare Part D | Not eligible under the 2026 rules — check your plan's Ozempic coverage and cost-sharing instead |
| Missing or incomplete prescriber section | Follow up with your provider's office to confirm the form was fully completed and signed |
| Missing Medicaid or Extra Help denial documentation | Request the denial letter from the relevant program before resubmitting |
9. Decision Tree: Do You Qualify?
If you don't meet the PAP's income or insurance requirements, compare NovoCare Pharmacy's self-pay price against Inside Rx and GoodRx.
10. If You Don't Qualify: Other Options
If Novo Nordisk's own program doesn't apply to your situation, a few other paths are worth checking before assuming you're stuck paying full price. Nonprofit clearinghouses like NeedyMeds and RxAssist maintain independent listings of manufacturer, state, and charitable assistance programs, and the Patient Advocate Foundation offers separate case-management support for people struggling to afford medication. Some patients also work with paid patient-advocacy services that apply to multiple programs on your behalf for a fee. If none of those pan out, compare the NovoCare Pharmacy self-pay price against Inside Rx and GoodRx's Ozempic pricing, since the gap between them can be significant depending on your specific situation.